This accordion works only on Content Type or Category archive pages.
Speaker Dawn Marshall (Tavalsky), Global External Manufacturing – Quality, Sanofi To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.
Speaker Louie Rayal, VP of Governance Risk and Compliance, GSK
Karen R. Zimm, Ph.D.Jeremy Banaszewski, M.S., Temple University Abstract This review article discusses the recent developments surrounding FD&C Red No. 3, a synthetic colorant utilized in various dosage forms. The significance of colorants in product identification and the implications of the FDA’s recent regulatory actions are examined. This article also analyzes historical perspectives, scientific evidence […]
Ronald D. Snee, PhDSnee Associates, LLC In the pharmaceutical world we talk a lot about Data Integrity. The FDA (2016) published A guidance for industry on matters involving data integrity. We hear analysts talking about Data Quality. Legal proceedings often question the “Chain of Custody of the Data.” Metadata is also of concern when assessing […]
Presented by: Rene Marcotte, Life Sciences, Senior Vice President, Delivery and Practice Management, RCM Technologies Artificial Intelligence (AI) has rapidly evolved from potential to reality. As organizations seek to leverage AI for process optimization and competitive advantage, the importance of data quality and governance has become paramount. AI’s ability to learn and make accurate decisions […]
